Search Results 471-480 of 15710 for varicella vaccine

  1. Mayo Clinic Q&A podcast: Breaking down COVID-19 vaccine booster approvals

    Poland talks more about the approval process for COVID-19 vaccine boosters, including for the Moderna and Johnson & Johnson COVID-19 vaccines. He also discusses ...

  2. A Study To Evaluate the Effectiveness, Safety, And Tolerability of a Clostridium Difficile Vaccine In Adults 50 Years of Age and Older - Mayo Clinic

    Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium ...

  3. Immune globulin-dira (intravenous route) - Mayo Clinic

    Smallpox Monkeypox Vaccine, Live Non-Replicating; Smallpox Vaccine; Torsemide; Typhoid Vaccine, Live; Varicella Virus Vaccine, Live; Yellow Fever Vaccine ...

  4. Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer - Mayo Clinic

    The purpose of this study is to look at the safety and immune response to a vaccine used in patients previously treated for HER2 (human epidermal growth factor ...

  5. Baricitinib (oral route) - Mayo Clinic

    Smallpox Vaccine; Teriflunomide; Tocilizumab; Typhoid Vaccine, Live; Upadacitinib; Ustekinumab; Vadadustat; Varicella Virus Vaccine, Live; Voriconazole; Yellow ...

  6. Valacyclovir (oral route) - Mayo Clinic

    It is also used to treat chickenpox and cold sores in children. In your body, valacyclovir becomes the anti-herpes medicine, acyclovir. Although valacyclovir ...

  7. Mayo Clinic Minute: Importance of flu vaccine

    This year, two flu vaccines for seniors are available. "Now we have an adjuvanted vaccine to boost the immune response to the influenza component. So people age ...

  8. Emergency use authorization for COVID-19 vaccines - Mayo Clinic News Network

    ... vaccine in children 5–11. "An emergency use authorization is a mechanism that exists within the Food and Drug Administration to provide accelerated ...

  9. A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor - Mayo Clinic

    A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a ...

  10. Science Saturday: Uncovering disparities in local communities - the case of the HPV vaccine

    Yet vaccination with the HPV vaccine has lagged considerably compared to national health and wellness goals. Recent Mayo Clinic research sought to understand ...